Amyloid in central nervous system disease.
A review is presented of diseases of the central nervous system associated with amyloid deposition. The name amyloid is given to substances with particular physical characteristics which are independent of the chemical constitution of the proteins in the substance. Ideally, a classification of amyloid diseases should be based on the chemical composition of the amyloid deposits; this has only been partially realized. The best documented group of diseases with amyloid deposition in the central nervous system is the group of 'cerebral beta amyloid diseases', characterized by the deposition of beta-protein. This group includes: Alzheimer's disease, sporadic cerebral amyloid angiopathy, Down's syndrome, Parkinson-dementia of Guam, hereditary cerebral hemorrhage with amyloidosis-Dutch type and age-related asymptomatic amyloid angiopathy.
Haan
J
J
Department of Neurology, University Hospital, Leiden, The Netherlands.
Roos
R A
RA
D000682:Amyloid / Q000032:analysis* / Q000145:classification; D000686:Amyloidosis / Q000473:pathology*; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000473:pathology*; D006801:Humans
D000682:Amyloid